Falling between the cracks: a case of amiodarone toxicity

Mackenzie, Constanze; Syed, Jaffer; Pollak, Timothy; Koren, Gideon
September 2011
CMAJ: Canadian Medical Association Journal;9/6/2011, Vol. 183 Issue 12, p1393
Academic Journal
Case Study
The article presents a case study of a 64-year-old woman who had a history of nausea, diarrhea, and vomiting. She was found having multisystem amiodarone toxicity, which includes pulmonary, hepatic, and thyroid toxicity. The article discusses amiodarone toxicity, which is induced by the pharmacodynamic and pharmacokinetic properties of the drug itself.


Related Articles

  • Potter's potions. McGregor, A. C.; MacMillian, M. H.; Ferguson, J. // Emergency Medicine Journal;Apr2008, Vol. 25 Issue 4, p217 

    The article reports on the medical case of a 36-year-old man who complained of tingling and peri-oral numbness after drinking tea made of Aconitum napellus. After taking magnesium sulphate and intravenous amiodarone the man developed pulseless ventricular tachycardia and severe metabolic...

  • Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Lepore, Mauro; Fanelli, Carmine; Porcellati, Francesca; Bartocci, Linda; Di Vincenzo, Antonio; Cordoni, Cristina; Costa, Emanuela; Brunetti, Paolo; Bolli, Geremia B.; Lepore, M; Pampanelli, S; Fanelli, C; Porcellati, F; Bartocci, L; Di Vincenzo, A; Cordoni, C; Costa, E; Brunetti, P; Bolli, G B // Diabetes;Dec2000, Vol. 49 Issue 12, p2142 

    To compare the pharmacokinetics/dynamics of the long-acting insulin analog glargine with NPH, ultralente, and continuous subcutaneous (SC) infusion of insulin lispro (continuous subcutaneous insulin infusion [CSII]), 20 C-peptide-negative type 1 diabetic patients were studied on four occasions...

  • Insulin Aspart (B28 Asp-Insulin): A Fast-Acting Analog of Human Insulin. Mudaliar, Sunder R.; Lindberg, Fedon A.; Joyce, Mary; Beerdsen, Patricia; Strange, Poul; Lin, Alan; Henry, Robert A. // Diabetes Care;Sep99, Vol. 22 Issue 9, p1501 

    Presents a study which examined the pharmacokinetic and pharmacodynamic profile of insulin aspart after subcutaneous administration in the deltoid, abdominal, and thigh sites. Methodology; Results; Conclusions.

  • Use of clinical judgment with amiodarone suggested. Kalvaitis, Katie // Endocrine Today;5/10/2008, Vol. 6 Issue 8, p8 

    The article discusses the safeness of using amiodarone to treat hyperthyroidism. The drug poses a serious safety concern as some patients develop thyrotoxicosis, says Gilbert H. Daniels, MD. The manifestation of amiodarone-induced thyrotoxicosis can start months or years following the intake of...

  • TOO MUCH OF A Good Thing. Fiedler, Chrystle // Better Homes & Gardens;Apr2004, Vol. 82 Issue 4, p320 

    Looks into the adverse effects of excessive use of over-the-counter drugs in the U.S. Rebound effect of over-the-counter medications if overused; Definition of rebound effect; Roster of common rebound-causing medications; Management for rebound effect.

  • Beta-Adrenergic Blocking Drugs: Pharmacokinetics and Pharmacodynamics. Ferguson, Roger K. // JAMA: Journal of the American Medical Association;5/12/89, Vol. 261 Issue 18, p2708 

    Replies to an inquiry about beta-adrenergic blocking drugs. Pharmacokinetics and pharmacodynamics; Dosage range; Mechanism of action.

  • New therapeutic agents marketed in the second half of 2007. Hussar, Daniel A. // Pharmacy Today;Mar2008, Vol. 14 Issue 3, p79 

    Objective: To provide information regarding the most important properties of the new therapeutic agents marketed in the second half of 2007. Data sources: Product labeling supplemented selectively with published studies and drug information reference sources. Study selection: By the author. Data...

  • Clinical Pharmacology of Dronedarone: Implications for the Therapy of Atrial Fibrillation. Dorian, Paul // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2010 Supplement, Vol. 15 Issue 4, p15S 

    Dronedarone, a recently approved antiarrhythmic agent, is a chemical analog of amiodarone. It has an approximately 15% bioavailability, with plasma concentrations markedly increasing after a high-fat meal; it is recommended to be taken with food. The primary metabolic clearance pathway for...

  • Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics. Becquemont, L.; Neuvonen, M.; Verstuyft, C.; Jaillon, P.; Letierce, A.; Neuvonen, P. J.; Funck-Brentano, C. // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p679 

    The aim of this study was to determine the influence of amiodarone on the pharmacokinetics of simvastatin and pravastatin in humans. This was a prospective, crossover, randomized, open-label study performed in 12 healthy volunteers comparing the pharmacokinetics of a single oral dose of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics